Most of the bio companies ARK invests in are US-based, and we do not believe tariffs will impact them. In fact, we view recent tariff policies as a tailwind accelerating the growth of the US biotech footprint. Research Analyst Nemo Marjanovic, PhD discusses our biotech strategy in this askARK.

Similar Posts